ADENOCAP Trademark

Trademark Overview

On Friday, July 10, 2020, a trademark application was filed for ADENOCAP with the United States Patent and Trademark Office. The USPTO has given the ADENOCAP trademark a serial number of 90047777. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2024. This trademark is owned by ImmunityBio, Inc.. The ADENOCAP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of COVID-19 and human adenovirus infections for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of COVID-19 and human adenovirus infections; diagnostic kits for COVID-19 and human adenovirus infections for medical or clinical use; vaccines for COVID-19 and human adenovirus infections

General Information

Serial Number90047777
Word MarkADENOCAP
Filing DateFriday, July 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of COVID-19 and human adenovirus infections for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of COVID-19 and human adenovirus infections; diagnostic kits for COVID-19 and human adenovirus infections for medical or clinical use; vaccines for COVID-19 and human adenovirus infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNANTCELL, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCULVER CITY, CA 90232
Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCulver City, CA 90232
Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCulver City, CA 90232

Trademark Events

Event DateEvent Description
Tuesday, July 14, 2020NEW APPLICATION ENTERED
Friday, August 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 4, 2021ASSIGNED TO EXAMINER
Wednesday, February 10, 2021PRIORITY ACTION WRITTEN
Wednesday, February 10, 2021PRIORITY ACTION E-MAILED
Wednesday, February 10, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, August 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 12, 2022SOU TEAS EXTENSION RECEIVED
Thursday, May 12, 2022SOU EXTENSION 1 FILED
Thursday, May 12, 2022SOU EXTENSION 1 GRANTED
Saturday, May 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 11, 2022SOU EXTENSION 2 FILED
Friday, November 11, 2022SOU EXTENSION 2 GRANTED
Tuesday, November 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 8, 2023SOU EXTENSION 3 FILED
Monday, May 8, 2023SOU EXTENSION 3 GRANTED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 4 FILED
Monday, November 13, 2023SOU EXTENSION 4 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2024SOU EXTENSION 5 FILED
Thursday, May 16, 2024SOU EXTENSION 5 GRANTED
Thursday, May 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

adenocap covid infections adenovirus human pharmaceutical diagnostic clinical preparations treatment kits